PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$16.09
−3.25%Forward multiples
Based on analyst estimates
- P/E forward
- 6.48x
- P/E 2026E
- 7.48x
- P/E 2027E
- 6.86x
- P/E 2028E
- 6.11x
- P/S forward
- 0.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.89x
- Price / sales
- 0.54x
- Price / cash flow
- 8.87x
Enterprise value
- Enterprise value
- $5.1B
- EV / sales
- 1.24x
- EV / EBITDA
- -4.90x
- EV / EBIT
- 23.85x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026